Fishy Executive Compensation at Northfield Labs
Related Stocks: NFLD David Phillips (10Q Detective) submits: In its recent proxy statement, Northfield Laboratories (NFLD), which is developing a hemoglobin-based oxygen-carrying red blood cell substitute (PolyHeme) for the treatment of urgent, large volume blood loss in trauma, revealed that its Chief Executive Officer, Steven A. Gould, M.D., received $365,000 in base salary and was awarded a $100,000 cash bonus. Complete Story » biotech.seekingalpha.com |
Bristol-Myers, AstraZeneca Face Damages
A federal court entered damages against AstraZeneca and Bristol-Myers in a suit related to "marketing the spread" of certain drugs, according to law firms. feeds.wsjonline.com |
Doctors have no cure for lack of good office space
When cardiologist Sonny Wong wanted to branch out and open his own solo practice after more than 20 years in medicine, it took him about six months to find the right space. feeds.bizjournals.com |
Lawmakers dissect COPIC
Colorado's largest medical malpractice insurance company is under increased scrutiny as state legislators consider a bill to raise caps on medical malpractice lawsuits. feeds.bizjournals.com |
Alta Bates Summit opens $13M Breast Health Center
Alta Bates Summit Medical Center, with hospital campuses in Berkeley and Oakland, opened its $13 million Carol Ann Read Breast Health Center March 10, officials said Friday. feeds.bizjournals.com |